Effectiveness of implant therapy in Sweden
نویسنده
چکیده
..................................................................................................................... 1 SAMMANFATTNING PÅ SVENSKA .................................................................................... 3 LIST OF PAPERS............................................................................................................... 5 ABBREVIATIONS............................................................................................................. 7 INTRODUCTION............................................................................................................... 9 ............................................................ Implant-supported restorative therapy 9 Patient-reported outcome measures following implant-supported restorative ........................................................................................................... therapy 11 ............. Biological complications of implant-supported restorative therapy 15 ............... Data analysis in studies on implant-supported restorative therapy 28 AIM.............................................................................................................................. 31 STUDY SAMPLE AND METHODS.................................................................................... 33 ................................................................................................. Study sample 33 ......................................................................................................... Methods 35 RESULTS....................................................................................................................... 51 Patient-reported outcome measures following implant-supported restorative ........................................................................................................... therapy 51 ................................................................................................... Implant loss 54 ............................................ Prevalence of peri-implant health and diseases 55 ............................ Factors associated with implant loss and peri-implantitis 57 .................................... Onset and pattern of progression of peri-implantitis 59 MAIN FINDINGS............................................................................................................ 63 CONCLUDING REMARKS............................................................................................... 65 ........................................................................... Evaluation of effectiveness 65 ........................................................................................ Outcome measures 68 ......................................................................................................... Findings 69 .................................................................... Consequences of complications 71 ACKNOWLEDGEMENT................................................................................................... 75 REFERENCES ................................................................................................................ 77 APPENDIX..................................................................................................................... 89
منابع مشابه
Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden
Background The inclusion of cost-effectiveness data, as a basis for priority setting rankings, is a distinguishing feature in the formulation of the Swedish national guidelines. Guidelines are generated with the direct intent to influence health policy and support decisions about the efficient allocation of scarce healthcare resources. Certain medical conditions may be given higher priority ran...
متن کاملTreatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations.
AIM To compare treatment costs with alternative luteinizing hormone-releasing hormone (LHRH) agonist preparations and determine whether a leuprorelin solid implant is associated with potential cost savings. PATIENTS & METHODS A hypothetical population of 1000 prostate cancer patients was apportioned between the three most commonly-prescribed LHRH agonist preparations. Differentiated annual co...
متن کاملIncorporating Cost-Effectiveness Data in a Fair Process for Priority Setting Efforts; Comment on “Use of Cost-Effectiveness Data in Priority Setting Decisions: Experiences from the National Guidelines for Heart Diseases in Sweden”
Cost-effectiveness data is useful for use in priority setting decisions in order to improve the efficiency of resources used. This paper thereby responds to Eckard et al. which addressed the use of cost-effectiveness data in the actual prioritization decisions in the Swedish national clinical guidelines for heart diseases. Based on a set of experiences on the use of economic evaluation in prior...
متن کاملIncluding Both Costs and Effects – The Challenge of Using Cost-Effectiveness Data in National-Level Policy-Making: A Response to Recent Commentaries
متن کامل
The clinical effectiveness of screw type Implant “Nisastan system” in the posterior region of the mandible: A 2 year prospective study
The clinical effectiveness of screw type Implant “Nisastan system” in the posterior region of the mandible: A 2 year prospective study Dr. M. Rismanchian * - Dr. R. Birang ** * Assistant Professor of Fixed Prosthodontics Dept., Faculty of Dentistry, Isfahan University of Medical Sciences. ** Assistant Professor of Periodontics Dept., Faculty of Dentistry, Isfahan University of Medical Sciences....
متن کامل